To study how the drug-altered cell morphology affects the AI prediction, we cultured prostate cancer cells (LNCaP) and treated them with Enza, which impairs cell growth and alters cell metabolism through androgen receptor inhibition. The gene discussed is AR; the disease is Familial prostate cancer.